Pricing Log in Create free account

MARKER THERAPEUTICS, INC. (MRKR) vs Vaxxinity, Inc. (VAXX)

MARKER THERAPEUTICS, INC. and Vaxxinity, Inc. are both Biotechnology companies. MARKER THERAPEUTICS, INC. and Vaxxinity, Inc. are of similar size ($15.5M and $14.9M). Across the 11 metrics below, MARKER THERAPEUTICS, INC. leads on 6 and Vaxxinity, Inc. on 5.

Valuation

Metric MRKR VAXX Biotechnology median
P/E n/m n/m 10.60
P/S 5.01 n/m 9.40
P/B 1.46 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.30 0.66
EV/Sales 1.88 (94.20) 9.02
Earnings yield (49.75%) 0.00% (32.88%)
Free cash flow yield (123.23%) 0.00% (23.13%)

Profitability

Metric MRKR VAXX Biotechnology median
Gross margin 134.12% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (76.87%) (150.65%) (51.96%)
Return on assets (59.33%) (75.55%) (46.06%)
Return on invested capital (566.75%) 0.00% 0.00%

Growth

Metric MRKR VAXX Biotechnology median
Revenue growth (TTM) (46.19%) — 6.76%
EPS growth (last fiscal year) 33.61% 25.00% 29.88%
Revenue growth, 5-year CAGR 50.02% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric MRKR VAXX Biotechnology median
Debt to equity 0.07 0.99 0.00
Current ratio 6.03 1.89 4.97
Net debt to EBITDA 1.32 0.30 1.01

Dividend

Metric MRKR VAXX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MRKR VAXX Biotechnology median
Market cap 14.93m 15.47m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack